Hsp90 regulates the Fanconi anemia DNA damage response pathway

Area of Science:

• Molecular Biology
• Cellular Biology
• Genetics

Background:

• Heat shock protein 90 (Hsp90) is a key regulator of cellular signaling pathways.
• Hsp90 inhibitors like 17-AAG show potential in cancer therapy by enhancing DNA damage-induced cell death.
• The precise mechanisms by which Hsp90 influences genotoxic stress responses remain largely unknown.

Purpose of the Study:

• To investigate the role of Hsp90 in regulating cellular responses to genotoxic stress.
• To elucidate the involvement of the Fanconi anemia (FA) pathway in Hsp90-mediated genotoxic stress response.
• To identify FANCA as a novel client protein of Hsp90.

Main Methods:

• Investigated the association between Hsp90 and FANCA using in vivo and in vitro assays.
• Utilized the Hsp90 inhibitor 17-AAG to disrupt the FANCA/Hsp90 interaction.
• Assessed the impact of 17-AAG treatment on FANCA protein stability, localization, and FANCD2 activation.
• Evaluated the effects of 17-AAG on DNA cross-linker-induced cytotoxicity and chromosome aberrations in both normal and FA pathway-defective cells.

Main Results:

• Hsp90 directly associates with FANCA in a manner sensitive to 17-AAG.
• Treatment with 17-AAG leads to rapid proteasomal degradation and cytoplasmic relocalization of FANCA.
• Disruption of the FANCA/Hsp90 interaction impairs the activation of FANCD2, a critical event in the FA pathway.
• 17-AAG enhances DNA cross-linker-induced cytotoxicity and chromosome aberrations, with a less pronounced effect in FA pathway-defective cells.

Conclusions:

• FANCA is identified as a novel client protein of Hsp90.
• Hsp90 plays a critical role in maintaining FANCA stability and nuclear localization.
• Hsp90 promotes the activation of the Fanconi anemia pathway by regulating FANCA turnover and trafficking.
• This regulation by Hsp90 is essential for cellular tolerance against genotoxic stress.